Atlas Trials

A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041

Clinical trial NCT04279613 · COMPLETED

Trial details

NCT number
NCT04279613
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type I Diabetes
Start date
2020-11-23
Primary completion
2023-08-31
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.